Controlling programmed cell death with a cyclophilincyclosporin-based chemical inducer of dimerization  by Belshawl, Peter J. et al.
Research Paper 731 
Controlling programmed cell death with a cyclophilin- 
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and Stuart L Schreiberl 
Background: Cell death can occur either from physical damage (necrosis) or 
cellular suicide (apoptosis). Apoptosis is essential for the development of 
multicellular organisms and disregulated apoptosis underlies many human 
diseases. The Fas receptor (Fas) is a membrane signaling protein that mediates 
a death signal following its aggregation by the Fas ligand. We have described 
methods to induce the association of proteins using cell-permeable molecules 
called chemical inducers of dimerization (CIDs). Here we describe the synthesis 
of a novel CID, (CsA),, that has two identical protein-binding surfaces derived 
from the immunosuppressant cyclosporin A (CsA). We use this CID to deliver a 
death signal to cells expressing a fusion protein containing cyclophilin (CyP, the 
protein receptor for cyclosporin) and the cytoplasmic signaling domain of Fas. 
Results: (CsA), was synthesized in six synthetic steps and 30 % overall yield 
from cyclosporin. It binds to two CyP proteins simultaneously, but does not 
inhibit T-cell signaling, presumably because the (CsA),-CyP complex does not 
bind to calcineurin. Jurkat cells stably transfected with constructs encoding 
myristoylated CyP-Fas fusion proteins undergo apoptosis in response to 
nanomolar quantities of (CsA),. Constructs containing a mutation in the 
myristoylation signal are defective for signaling. 
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Conclusions: The Fas signaling pathway can be activated with a cell-permeable 
CID derived from CsA in cells expressing an appropriately engineered Fas 
construct, which must be localized at the membrane. This new class of 
homodimerizing ClDs will be useful for in-depth analysis of protein association 
events in complex systems, including transgenic animals. Now that several ClDs 
with distinct dimerization characteristics are available, it should be possible to 
induce the activation of multiple pathways with complete specificity. 
Introduction 
Cell death can occur by one of two processes, termed 
necrosis and apoptosis. In necrosis, physical damage to a 
cell causes a loss of membrane integrity, and death is 
usually accompanied by osmotic swelling and bursting of 
the cell. Apoptosis or programmed cell death (PCD) 
occurs primarily in multicellular organisms and is an 
active process in which a cell commits suicide for the 
benefit of the whole organism. This mode of cell death is 
recognized by characteristic morphological features 
including cytoplasmic and nuclear shrinkage, inter- 
nucleosomal fragmentation (genomic DNA is fragmented 
at -180 bp intervals), degradation of cellular components, 
and a loss of membrane integrity [ 11. Several components 
of the apoptotic machinery have been identified, 
originally through genetic studies in nematodes [Z]. 
Apoptosis mediated by the Fas receptor (Fas) has 
received special attention because of its exquisite 
specificity and its role in lymphoproliferative disorders [3]. 
Fas [4] (also known as APO-l [S] or CD-95) is a type I 
transmembrane protein belonging to the tumor necrosis 
factor receptor (TNFR) superfamily of proteins (the 
name tumor necrosis factor is a misnomer, however, since 
this receptor causes cell death by apoptosis rather than by 
necrosis). Within this family, Fas and TNFR can cause 
apoptosis when engaged by their respective ligands. 
These proteins have homologous sequences within their 
intracellular domains, termed death domains, that contain 
the information necessary to trigger the apoptotic signal. 
Recently, several proteins that interact with Fas and/or 
TNFR have been identified [6-101. Two of these, 
MORTl/FADD and TRADD can associate with each 
other as well as with Fas and TNFR, respectively, and 
thereby connect Fas and TNFR to their common down- 
stream effector MACHl/FLICE [ll-131. MACHl/FLICF 
is a cysteine protease that is homologous to the 
ICE/CED-3 family of proteases and is activated upon 
signaling by Fas. Although the precise mechanism of 
activation of MACHl/FLICE by Fas and TNFR remains 
obscure, the likelihood that these receptors are activated 
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by aggregation led us to apply the chemical inducer of 
dimerization (CID) concept to this signaling pathway. 
Physical contact between two or more molecules is 
required to relay information in signal transduction. Two 
outcomes to this interaction are possible; either the 
interaction results in a conformational change that 
facilitates the transfer of information (allostery), or it results 
in the localization of a molecule to the vicinity of an inter- 
acting partner or substrate (proximity) [14]. We previously 
described a technique for regulating the proximity of 
proteins with synthetic, cell-permeable molecules termed 
CIDs [ 151. In the first illustration of this concept, a dimeric 
version of the naturally occurring ligand FK506 was 
synthesized, creating FKlOlZ, a molecule with two 
protein-binding surfaces. A human T-cell line was trans- 
fected with a plasmid encoding a chimeric protein comp- 
osed of three copies of human FKBP12 (the high affinity 
protein receptor for FK.506 and rapamycin) [16,17] fused to 
5, a signaling component of the multisubunit T cell recep- 
tor (TCR). The addition of FK1012 to cells expressing this 
fusion protein aggregates the 5 fusion, thereby activating 
the endogenous TCR signaling pathway [15,18]. 
Since this original demonstration, FK101’2 has been used 
to dimerize membrane receptors that activate the platelet- 
derived growth factor (Jianxin Yang, Mark Mercola and 
S.L.S. unpublished data) and Fas [19] pathways, and to 
recruit cytosolic signaling proteins that activate the 
Ras/MAPK [ZO] and Src [Zl] pathways. FK1012 can also 
signal in the nucleus, where transcription of a reporter 
gene is induced following the FKlOlZ-mediated re- 
assembly of two separated domains of a transcription factor 
[ZZ]. Notably, FK1012 has also been shown to activate 
signaling in transgenic mice, demonstrating the potential 
for CIDs to be used to investigate signaling in viva [19]. 
To expand this approach, we sought an additional 
receptor-ligand pair that could be modified into a dimer- 
ization domain and CID. Ideally, receptor-CID complexes 
Figure 1 
should have high affinity, the CID should be cell 
permeable, the receptor should be monomeric, and neither 
the receptor nor the CID should have discernible effects on 
cells alone. The monomeric, 18-kDa cyclophilin (CyP) 
receptor and its cell-permeable ligand cyclosporin (CsA) 
bind with high affinity (Kd = 5 nM) [23] and thus appeared 
to be a promising system for development [24]. We have 
also created new receptor-ligand pairs based on CyP-CsA 
[‘23] by first modifying a residue of CsA such that it can no 
longer bind wild-type CyI? We then introduced compen- 
satory mutations in the binding site of CyP such that the 
new CyP mutants gained the ability to bind the modified 
CsA. In this way, many such independent, non cross- 
reacting receptor-ligand pairs may be generated, each with 
the potential to be developed as a CID. 
Like FK506, CsA’s immunosuppressive and toxic 
properties are due to its ability to form an immunophilin 
complex that inhibits the protein phosphatase calcineurin 
[ZS]. When FK506 was converted into FK1012, the dimeric 
molecule was designed to be unable to form the complex 
surface that binds to calcineurin. Similarly, the conversion 
of CsA into its CID form required the rational removal of 
calcineurin-inhibitory properties. We now describe the 
synthesis of the cell-permeable CID (CsA),, and its use as 
an inducer of cell death in cells expressing a CID- 
responsive Fas receptor (Fig. 1). 
Results 
Synthesis of a CID derived from CsA 
We used the known conversion of CsA to MeBmt-n-OH- 
l-CsA (1) [26] to install a functional group at the terminus 
of MeBmt-1 through a selective free radical bromination. 
The primary hydroxyl of the dihydroxy intermediate (1, 
Fig. 2) was converted to an activated carbamate with 
carbonyl diimidazole, providing an intermediate (2) that 
can be used to generate monomers, homodimers, or 
heterodimers. Reaction of this intermediate with xylyl- 
enediamine provided (CSA)~. Reaction with benzylamine 
provided monomeric CsA-M (Fig. 2). 
CID-inducible activation of a cellular 
signaling pathway. A chimeric protein 
composed of cyclophilin fused to the 
cytoplasmic tail of the Fas receptor and 
localized to the membrane by a myristoyl 
group can be caused to aggregate by the 
addition of the CID (CsA),. When the Fas tail 
is aggregated, the normal Fas signaling 
pathway is activated, leading to cell death. 
-’ 
:I, - death 
3% 
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In vitro demonstration of 2:l binding stoichiometry 
To determine whether (CSA)~ has the ability to bind two 
molar equivalents of CyP simultaneously, we performed 
titration binding assays for CsA-M and (CsA), with 
recombinant CyP The assay relies on an approximately 
two-fold increase in CyP’s fluorescence upon binding CsA 
[23,27]. The results show that (CsA), can bind two molar 
equivalents of CyP whereas CsA-M can bind only one, as 
expected (Fig. 3). 
Assessment of (CsA), and CsA-M inhibition of TCR signaling 
The immunosuppressive properties of cyclosporin result 
from its ability to inhibit calcineurin when complexed 
with cyclophilin [ZS]. Calcineurin is a component of the 
TCR signaling pathway and is essential for induction of 
the transcription factor NFAT [28]. We used a cellular 
NFATsignaling assay in which Jurkat T cells have been 
stably transfected with an NFATresponsive P-galacto- 
sidase (P-gal) reporter gene [‘29]. Stimulation of these cells 
with ionomycin and phorbol myristate acetate (PMA) 
Figure 2 
mimics activation of the TCR, induces NFAT, and causes 
the production of P-gal. As seen in Figure 4, CsA potently 
inhibits the production of P-gal activity, CsA-M has 
significantly reduced inhibition, and (CsA), shows no 
inhibitory effects, even at 10 pM. 
Regulation of Fas-mediated apoptosis with (CsA), 
We prepared a series of DNA constructs encoding fusion 
proteins composed of (from N to C) a myristoylation- 
targeting peptide (for membrane attachment), from one to 
three CyP domains in tandem, the intracellular domain of 
Fas, and an epitope tag. Constructs having a reverse order of 
Fas and the CyP domains, and control constructs lacking the 
Fas domain or containing a non-functional myristoylation 
signal 1301 were also prepared (Fig. 5). These were 
transiently transfected into Jurkat TAg cells along with an 
AP-l-responsive secreted alkaline phosphatase (SEAP) 
reporter plasmid [31]. 24 h after transfection the cells were 
stimulated with PMA and varying concentrations of (CsA), 
or CsA-M for 24 h, after which SEAP activity was measured. 
Me 
1. AczO 
2. NBS, AIBN 
* 
3. NEL,OAc 
4. NaOMe 
1. 2 equiv. 
(Im)zCO 
* 
Cyclosporin A (&A) 1 
2 CsA-M 
Synthesis of (CsA), and CsA-M from CsA. NBS = N-bromosuccinimide, AIBN = 2,2’-azobis(2-methylpropiononitrile), (Im)&O = 
carbonyldiimidazole. 
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Figure 3 Figure 5 
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Myristoylation signal from pp60c-s’c (residues l-l 4) 
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0 Chemistry & Biology, 1996 
Schematic representation of DNA constructs encoding the Cyp-Fas 
fusion proteins used in this study. 
100 200 300 400 so0 coo 700 
[(CsA)*] or [CsA-M] nM 
Fluorescence titration assays for (CsA), and CsA-M with cyclophilin A. 
The fluorescence change observed for cyclophilin is plotted against 
the concentration of ligand added. 
This provides an indirect assay for Fas signaling, since a 
reduction in the number of living cells decreases reporter 
gene expression. From the normalized data in Figure 6a it 
can be seen that all constructs in which the CyP domains 
precede Fas are capable of signaling, with MC3FE being 
the most effective. From the raw data in Figure 6b it can be 
seen that some of the constructs significantly reduce 
Figure 4 
inhibition of NFAT signaling pathway by CsA, CsA-M and (CsA), in 
Jurkat cells stably transfected with a 6-galactosidase reporter gene 
containing three tandem NFAT response elements within the minimal 
IL-2 promoter [29]. In 96-well plates, 1 O5 cells per well were 
stimulated with ionomycin (1 mM) and PMA (50 ng ml-‘) in the 
presence of varying concentrations of ligand. After 24 h, cells were 
assayed for 6-galactosidase activity. 
reporter gene expression even in the absence of (GSA),. 
Myristoylation was essential for activity, as AMC3FE was 
unable to signal. Western blots displaying the relative levels 
of expression of these constructs are shown in Figure 7. The 
constructs AMC3FE, MCZE and MC3E were expressed at 
high levels. MC3FE was expressed at a low level and the 
expression of MCZFE was barely detectable. MClFE and 
MFE had undetectable levels of expression. To test 
whether dimerization of Fas was essential for MC3FE 
signaling in our assay, cells were treated with CsA-M and 
(CsA), alone or in combination (Fig. 8). CsA-M had no 
effect on AP-1 signaling alone and (CsA), in the presence of 
excess CsA-M was no longer able to induce signaling. 
Based on the transient transfection data we decided to use 
MC3FE for the generation of stably transfected Jurkat T 
cell lines. Two such cell lines were derived and each 
showed >95 % apoptotic death following 24 h of 
stimulation with 100 nM (CsA),. The mode of death was 
clearly apoptotic, as assessed by an assay that reveals both 
cell morphology and viability (Fig. 9). 
Discussion 
In this study, we prepared conditional alleles (genes that 
produce a specific effect only under certain conditions) of 
Fas, encoding receptors designed to be activated by a CID 
derived from cyclosporin (Fig. 1). The early identification 
of Fas as a member of the TNFR superfamily suggested 
that receptor aggregation would initiate Fas signaling [32]. 
This expectation was supported by studies that used an 
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Figure 6 
Triggering of cell death by (CsA)s. The figure shows the results of 
transient expression experiments in Jurkat T cells stably transformed 
with large-T antigen. Cells were electroporated with a plasmid 
encoding a SEAP reporter gene under the control of three tandem 
APl -binding sites (AP-1 SEAP, 1 kg) along with an excess (5 kg) of a 
plasmid encoding the immunophilin fusion construct. After 24 h, the 
cells were stimulated with PMA (50 ng ml-‘) and (CsA),. At 48 h the 
cells were assayed for SEAP activity. (a) Data for each construct 
normalized relative to [(CsA),] = 0. (b) Data for each curve normalized 
relative to [(CsA),] = 0 for the MCBE construct. Each data point 
represents the average of triplicate experiments. 
antibody to crosslink the receptor [33] and a parallel study 
in which Fas chimeras responsive to FK1012 were used 
[19]. Controlling the Fas pathway with a cell-permeable 
CID was expected to facilitate an understanding of the 
mechanism of signaling, and has provided a way to 
selectively ablate cells targeted to express the conditional 
allele, for example, by using cell-specific promoters in 
transgenic animals [ 191. 
CsA is a natural CID, composed of immunophilin- and 
calcineurin-binding surfaces. To convert this natural 
heterodimerizer into a CID with two immunophilin- 
binding surfaces (a homodimerizer) and lacking a 
calcineurin-binding surface, we functionalized CsA at a 
position critical for calcineurin-binding and in a way that 
would enable two CsA molecules to be joined via a 
covalent linker. We chose a route that selectively 
derivatizes the terminus of the MeBmt-1 sidechain [26]. 
From previous studies, it was known that modifications at 
this site produced variants of CsA that no longer bind 
calcineurin, yet still retain the ability to bind CyP [34]. 
The synthesis outlined in Figure 2 provides (GSA), in 6 
steps and 30 % overall yield from CsA. As anticipated, a 
cellular signaling assay showed that even at concentrations 
as high as 10 Frn, (CsA), has no significant effect on the 
ability of PMA and ionomycin to stimulate the trans- 
cription factor NFAT, a process that requires the activ- 
ation of calcineurin. Surprisingly, the monomeric version 
of the CsA dimer, GA-M, showed some inhibition in this 
assay, although at a higher concentration than that of CsA. 
To examine the properties of (CsA), further, we tested 
whether this homodimerizer could bind to two CyP 
domains simultaneously. A fluorescence binding assay was 
used under conditions where the concentration of protein 
was greater than the expected K, for CyP-CsA, resulting 
in a titration binding assay. The binding curves show 
clearly that two equivalents of CyP bind one equivalent of 
(CsA), as the fluorescence approaches saturation when the 
concentration of (CsA), is -50 % of the concentration of 
CyP, whereas for CsA-M saturation occurs when the 
concentrations are equal. 
In a transient transfection assay for Fas signaling (Fig. 6a), 
we found that constructs containing one, two, or three 
CyP domains preceding the intracellular Fas domain 
(MCnFE, n=1,2,3) could activate the Fas signaling 
pathway in response to (CsA),; the MCSFE receptor was 
most effective. In contrast, the monomeric ligand, CsA-M, 
alone had no effect on the PMA-induced AP-1 reporter 
gene in cells transfected with MCSFE and was able to 
prevent (CsA&,-induced signaling when added in excess 
(Fig. 8), indicating that dimerization is required for 
signaling. Constructs lacking the Fas domain or containing 
a non-functional myristoylation signal were unable to 
signal, demonstrating that membrane association is 
required for signaling. These results were fully consistent 
with similar experiments using FK1012. Constructs 
containing the Fas domain alone, or in which the Fas 
domain preceded the cyclophilin domains had no 
apparent activity. This was probably due to an auto- 
signaling effect since cells co-transfected with an excess of 
these constructs and a reporter gene showed little or no 
reporter gene activity when stimulated with ionomycin 
and PMA alone, suggesting that cells receiving both 
plasmids were eliminated by apoptosis during the 24-h 
recovery period (Fig. 6b). Western blots (Fig. 7) support 
this theory as the expression levels of Fas-containing 
constructs are inversely proportional to the level of ligand- 
independent signaling for each construct. Inactive and 
non-toxic constructs lacking the myristoylation signal or 
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Figure 7 
Western blots of Jurkat-TAg cells transfected with plasmids encoding the 
indicated constructs. The anticipated positions of bands corresponding 
to the transfected plasmids are indicated with small arrows. 28 h after 
electroporation, soluble proteins in cell lysates were separated on a 
10 o/o SDS-PAGE gel and transferred to nitrocellulose. Blots were 
probed with primary (anti-hemagglutinin antibody 12045, BABCO) and 
secondary (goat-anti-mouse horseradish peroxidase conjugate, 
Amersham) antibodies followed by ECL detection (Amersham). 
Figure 8 
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Dimerization of the Fas construct MCBFE is essential for signaling. The 
figure shows the effect of (CsA), and CsA-M on PMA-induced reporter 
gene activity in Jurkat-TAg cells transiently transfected with MCBFE and 
AP-1 SEAP, normalized to the value in the absence of ligand. Cells 
were assayed by the protocol detailed in the legend for Fig. 5. 
Experiments were done in triplicate; standard errors are indicated. 
the Fas domain show a strong level of expression, further 
implicating Fas in cellular toxicity. Finally, the intra- 
cellular domain of Fas has been shown to self-associate 
and signal cell death [9,35]. 
Human Jurkat T-cell lines stably transfected with MC3FE 
clearly show the morphological features of apoptosis, with 
nuclear condensation and fragmentation visible within 6 h 
of treatment with (CsA& (IC,, -50 nM, Fig. 9). After 24 h 
of treatment with 100 nM (CsA&, 2 90 % cell death 
occurred as measured by Tiypan Blue exclusion. 
The crystal structure of the extracellular domain of 
TNFR complexed with its ligand shows that the complex 
is a trimer of the ligand bound to three receptor domains 
with C3 symmetry 1361. As there is extensive homology 
between the Fas ligand and TNF and between the 
extracellular ligand-binding domains of Fas and the 
TNFR, it has been hypothesized that Fas ligand induces 
Fas signaling through trimerization of Fas. Our results 
indicate that trimerization may not be necessary for 
signaling since the construct MClFE is able to signal 
when treated with (CsA),, a process that can only directly 
result in the dimerization of Fas. However, we cannot rule 
out the possibility that dimerization results in a high 
affinity binding site for a third Fas intracellular domain. 
Viewed in light of the discovery of MACHUFLICE, a 
pro-enzyme that must be proteolysed to release the active 
soluble ICE/CED-3-like protease domains, a simple 
model can be made in which dimerization of Fas mediates 
dimerization of MACHl/FLICE and activation of the 
protease. The proteolytic processing of MACHl/FLICE 
could occur by trans-proteolysis, analogous to the trans- 
phosphorylation induced by dimerization of receptor 
tyrosine kinases, where homodimerization increases 
the local concentration of these proteases, facilitating 
self-processing of MACHUFLICE and delivery of an 
apoptotic signal. 
The development of a second designed CID has opened 
up possibilities for the study of complex protein assoc- 
iation events where multiple proteins are recruited to one 
or more sites in a cell. The CyP-CsA system and, in 
particular, the active carbamate of CsA (2, Fig. 2) has also 
been used in the synthesis of a heterodimeric CID, 
FKCsA, a molecule that can bind FKBP and CyP simult- 
aneously [37]. FKCsA allows the specific hetero- 
dimerization of two disparate proteins to be accomplished 
with high specificity [37]. Because membrane association 
is required for Fas signaling and cellular toxicity, cell 
death can also be controlled through the inducible 
recruitment and aggregation of cytosolic Fas-containing 
proteins to a membrane docking protein with FKCsA [37]. 
This approach may provide a more tightly regulated death 
signal since the non-myristoylated Fas-containing proteins 
do not cause cell death through auto-association. FKCsA 
was also used to recruit a cytoplasmic protein to 
the nucleus and a transcriptional activation domain to a 
target gene [37]. We anticipate that, using the new and 
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Figure 9 
(C&A), induces apoptosis in Jurkat ceils stably transfected with Cyp- 
Fas fusion proteins. Cells were photographed in growth media 
containing propidium iodide (50 kg ml-‘) and acridine orange 
(500 ng ml-‘). Acridine orange (green) accumulates in living cells with 
an intact membrane. Propidium iodide (red) stains DNA of dead or 
dying cells with leaky membranes. (a) Human Jurkat cells stably 
transfected with MCBFE plasmid. (b) Jurkat cells stably transfected 
with MCBFE plasmid treated with 500 nM (CsA), for 24 h. 
orthogonal CID-dimerization domain pair developed here 
together with the FKBPlZ-FK1012 system and the 
heterodimerizer FKCsA, we should now be able to 
independently activate multiple distinct pathways in a 
single cell or organism. For example, we now have tools to 
investigate signaling pathways for synergistic effects 
where multiple signaling proteins are independently 
activated or recruited to a common docking protein. 
Significance 
Cell-permeable CIDs can be used as equivalents of gain- 
of-function conditional alleles. The rationally designed 
CID synthesized in this study, (CSA)~, has been used 
together with a rationally designed conditional allele of 
the Fas receptor. The synthesis begins with the natural 
CID, CsA, and illustrates the strategy of creating new 
CIDs by synthetically joining protein-binding surfaces. 
The conditional allele encodes a fusion protein 
composed of a short N-myristoylated region followed by 
one to three CyP dimerization domains and the 
intracellular tail of the Fas receptor. When stably 
expressed in a human tumor T-cell line, the artificial 
receptor can be dimerized and activated with the 
synthetic (CsA), CID, resulting in apoptotic death of 
the T cells. Thus, a non-toxic molecule can be used to 
induce a lethal response in targeted cells. This cell 
ablation technique has already been shown to be useful 
in transgenic animals when combined with cell- or 
tissue-specific promoters, and it might even be useful in 
the treatment of tumors with non-toxic molecules when 
combined with gene delivery techniques (gene therapy). 
Materials and methods 
Fluorescence binding assay 
Fluorescence measurements were made on a Hitachi F2000 
fluorescence spectrometer following a 10 min incubation with ligand at 
20 “C. Excitation was at 280 nm, 10 nm bandwidth and 33/l 00 filter. 
Emissions were scanned at 300-400 nm, 10 nm bandwidth. CyPA 
was diluted to 300 nM in 3 ml Tris buffered saline pH 7.4. Small 
aliquots of ligand in 20 o/, ethanol were added between successive 
measurements such that the total volume added was Cl .5 %. 
Cell lines and tissue culture 
Jurkat-TAg [31] and Jurkat-NFAT-Z [29] cells were maintained in RPMI 
1840 media containing 10 o/, (v/v) fetal calf serum, t-glutamine and 
penicillin/streptomycin. For transfections, 1 O7 cells were electro- 
porated (BTX 800 electroporator, 250 V, 800 p.F, 129 R, 4 mm 
cuvettes in a total volume of 220 pJ of RPMI 1840) with 1 0-min 
incubations at room temperature before and after electroporation. 
Following each electroporation, cells were diluted to 10 ml in media 
and incubated overnight at 37 “C, pelleted, washed, resuspended in 
4 ml of medium and aliquoted into 98-well plates. 
SEAP assays 
Cells in 98-well plates were heated at 85-70 “C for 1.5 h to denature 
background phosphatases. 100 f.~l aliquots were transferred from each 
well to new plates containing 100 f~l of a solution of 4-methyl- 
umbelliferyl phosphate (1 mM, Sigma) in 2M diethanolamine 
bicarbonate pH 10 and incubated at 37 “C for 2-l 0 h. 
pgalactosidase assays 
Cells in 98-well plates were pelleted by centrifugation. Following 
aspiration of the medium, pellets were dissolved in 150 p,l of a solution of 
4-methylumbelliferyl-8-o-galactoside (0.6 mM, Sigma) in 68 mM phos- 
phate, 6.6 mM KCI, 0.66 mM MgSO,, 0.1 o/o Triton X-l 00, pH 7. After 
incubating at 37 “C for 2-l 0 h, aliquots were quenched with 75 f.d of 
300 mM glycine, 15 mM EDTA pH 11.2. Fluorescence measurements 
were made using a Fluoroscan II fluorescence plate reader (ICN). 
MeBmtfOH)-q-OCO-/ml-CsA 
MeBmt(OH)-n-OH’-CsA (38 mg, 31 pmol, 1218.6 g mol-I) and 
carbonyldiimidazole (20 mg, 4 eq., 124 p,mol, 162.15 g mol-l) were 
transferred into a lo-ml round bottom flask and dissolved in dry 
tetrahydrofuran (2 ml). Diisopropylethylamine (22 )LI, 4 eq., 125 p,mol, 
129.25 g mol-‘) was added and the solvent was removed on a rotary 
evaporator at room temperature. The residue was purified by flash 
chromatography on silica gel using O-20 % acetone in ethyl acetate as 
eluent to give 32 mg (78 % yield) of a white solid. 
(CsA),: xylyenediamine CsA dimer 
MeBmt(OH)-q-OCO-lml-CsA (12.5 mg, 9.52 p,mol, 1312.7 g mol-‘) 
was dissolved in dichloromethane (200 fd). To this solution was added 
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22 pl (0.5 eq., 4.75 pmol) of a solution of xylylenediamine (14.7 mg, 
136.2 g mol-‘) in dimethylsulfoxide (0.5 ml) and the reaction mixture 
was stirred for 72 h at room temperature under a nitrogen atmosphere. 
The reaction was diluted with acetonitrile (2 ml) filtered through glass 
wool and purified by reverse-phase high-pressure liquid chroma- 
tography (Beckman Cl 8, 10 )L, 100 A, 1 cm x 25 cm, 5 ml min-‘, 50 to 
90 % acetonitrile/water (+O.l O/o trifluoroacetate) over 30 min, 70 “C) to 
give 6.1 mg (49 % yield) of (CsA), as a white solid. 
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